- 抑制劑
- 化合物庫
- 抗體
- 生物試劑
- 新產(chǎn)品
- 聯(lián)系我們
別名: 17β-estradiol, β-Estradiol, E2, 17β-Oestradiol 中文名稱:雌二醇
Estradiol (17β-estradiol, β-Estradiol, E2, 17β-Oestradiol)是一種人類性激素和類固醇,也是主要的女性性激素。Estradiol 可通過 estrogen receptor β (ERβ) 通路來上調 IL-6 的表達。
Estradiol Chemical Structure
CAS: 50-28-2
細胞系 | 實驗類型 | 給藥濃度 | 孵育時間 | 活性描述 | 文獻信息 |
---|---|---|---|---|---|
MCF7 | Function assay | 1 nM | 24 hrs | Down regulation of estrogen receptor expression in MCF7 cells at 1 nM after 24 hrs | 17275315 |
MCF7 | Cytotoxicity assay | 4 uM | 24 hrs | Cytotoxicity against human MCF7 cells at 4 uM after 24 hrs by MTT assay | 21459581 |
MCF7 | Function assay | 4 uM | 24 hrs | Reduction in Cdk1 protein level in human MCF7 cells at 4 uM after 24 hrs by Western blot analysis | 21459581 |
MCF7 | Function assay | 0.01 nM | 48 hrs | Estrogenic activity in human ER-positive MCF7 cells assessed as secreted alkaline phosphatase activity at 0.01 nM after 48 hrs by phospha-light reporter chemiluminescence assay | 21800859 |
Ishikawa cells | Function assay | 0.1 nM | 72 hrs | Effect on cell proliferation of human Ishikawa cells at 0.1 nM after 72 hrs by MTT assay | 22464681 |
HeLa | Function assay | 1 nM | 20 to 24 hrs | Agonist activity at ERalpha receptor in human HeLa cells assessed as activation of ERalpha-based transcription at 1 nM after 20 to 24 hrs by luciferase reporter gene assay | 23448346 |
MCF7 | Function assay | 1 nM | 20 to 24 hrs | Agonist activity at ERalpha receptor in human MCF7 cells assessed as activation of ERalpha-based transcription at 1 nM after 20 to 24 hrs by luciferase reporter gene assay | 23448346 |
MCF7 | Function assay | 10 nM | 20 hrs | Induction of estrogen receptor-alpha degradation in human MCF7 cells at 10 nM after 20 hrs by Western blot analysis | 25879485 |
Saos2 | Function assay | 1 uM | 7 days | Agonist activity at ERalpha in human Saos2 cells assessed as induction of cell proliferation at 1 uM after 7 days by MTS assay | 27155470 |
Saos2 | Function assay | 0.1 nM | 3 days | Agonist activity at ERalpha in human Saos2 cells assessed as increase in ALP activity using p-nitrophenyl phosphate as substrate at 0.1 nM after 3 days by colorimetric assay | 27155470 |
MDA-MB-231 | Growth inhibition assay | 1 pM to 1 μM | 48 hr | Growth inhibition of Homo sapiens (human) MDA-MB-231 cells at 10'-12 to 10'-6 M after 48 hr by MTT assay | ChEMBL |
UMR106 | Function assay | 10 nM | 24 hrs | Transactivation of human ER-alpha transfected in rat UMR106 cells at 10'-8 M after 24 hrs by dual luciferase reporter gene assay | ChEMBL |
UMR106 | Function assay | 10 nM | 24 hrs | Transactivation of human ER-beta transfected in rat UMR106 cells at 10'-8 M after 24 hrs by dual luciferase reporter gene assay | ChEMBL |
U2OS | Function assay | 0.01 uM | 24 hrs | Activation of ERbeta (unknown origin) expressed in human U2OS cells at 0.01 uM incubated for 24 hrs by luciferase reporter gene assay | ChEMBL |
U2OS | Function assay | 0.01 uM | 24 hrs | Activation of ERalpha (unknown origin) expressed in human U2OS cells at 0.01 uM incubated for 24 hrs by luciferase reporter gene assay | ChEMBL |
COS7 | Function assay | 1 nM | Agonist activity at GFP-tagged ERalpha expressed in COS7 cells assessed as increase in intracellular calcium level at 1 nM by spectrofluorimetry | 16520733 | |
COS7 | Function assay | 1 nM | Agonist activity at GFP-tagged ERbeta expressed in COS7 cells assessed as increase in intracellular calcium level at 1 nM by spectrofluorimetry | 16520733 | |
COS7 | Function assay | 1 nM | Agonist activity at GFP-tagged ERalpha expressed in COS7 cells assessed as PI3K activation at 1 nM by PIP3 nuclear accumulation assay | 16520733 | |
COS7 | Function assay | 1 uM | Agonist activity at GFP-tagged ERbeta expressed in COS7 cells assessed as PI3K activation at 1 nM by PIP3 nuclear accumulation assay | 16520733 | |
COS7 | Function assay | 1 uM | Agonist activity at GFP-tagged GPR30 expressed in COS7 cells assessed as PI3K activation at 1 nM by PIP3 nuclear accumulation assay | 16520733 | |
COS7 | Function assay | 1 nM | Binding affinity to mRFP1-tagged GPR30 expressed in COS7 cells coexpressing GFP-tagged ERalpha assessed as inhibition of E2-Alexa633 binding in nucleus at 1 uM by FACS | 16520733 | |
COS7 | Function assay | 1 nM | Binding affinity to GFP-tagged ERalpha expressed in COS7 cells coexpressing mRFP1-tagged GPR30 assessed as inhibition of E2-Alexa633 binding in nucleus at 1 uM by FACS | 16520733 | |
MCF7 | Function assay | 1 uM | Down regulation of ERalpha human MCF7 cells at 1 uM by Western blotting | 23043242 | |
insect cells | Function assay | 0.1 to 10000 uM | Binding affinity to untagged human recombinant full length ERalpha expressed in insect cells 0.1 to 10000 uM by Fluormone ES2 Green displacement based assay | 30091920 | |
Ishikawa Var-1 cells | Function assay | 72 hrs | Estrogenic activity at estrogen receptor in human Ishikawa Var-1 cells assessed as stimulation of alkaline phosphatase activity measured by metabolism of p-nitrophenol phosphatase after 72 hrs, EC50=0.000047μM | 15568770 | |
SK-BR-3 | Function assay | 48 hrs | Inhibition of chemoattractant-induced cell migration of human SK-BR-3 cells after 48 hrs by transwell migration assay, IC50=0.0001μM | 16520733 | |
MCF7 | Function assay | 48 hrs | Inhibition of chemoattractant-induced cell migration of human MCF7 cells after 48 hrs by transwell migration assay, IC50=0.0004μM | 16520733 | |
MCF7 | Function assay | 6 days | Estrogenic activity in human MCF7 cells assessed as cell proliferation after 6 days by WST8 assay, EC50=0.0000037μM | 18760603 | |
HEC1 | Function assay | 24 hrs | Agonist activity at full-length human estrogen receptor beta expressed in human HEC1 cells assessed as transcriptional activation after 24 hrs by luciferase reporter gene assay, EC50=0.00013μM | 19128016 | |
HEC1 | Function assay | 24 hrs | Agonist activity at full-length human estrogen receptor alpha expressed in human HEC1 cells assessed as transcriptional activation after 24 hrs by luciferase reporter gene assay, EC50=0.0007μM | 19128016 | |
HEC1 | Function assay | 24 hrs | Agonist activity at ERalpha expressed in human HEC1 cells assessed as transcriptional potency after 24 hrs by luciferase-beta galactosidase reporter gene assay, EC50=0.0001μM | 19286283 | |
HEC1 | Function assay | 24 hrs | Agonist activity at ERbeta expressed in human HEC1 cells assessed as transcriptional potency after 24 hrs by luciferase-beta galactosidase reporter gene assay, EC50=0.0005μM | 19286283 | |
MCF7:WS8 | Function assay | 7 days | Estrogenic activity in human ERalpha expressing MCF7:WS8 cells assessed as stimulation of cell proliferation after 7 days, EC50=0.000001μM | 20334368 | |
HEK293 | Function assay | 18 hrs | Transactivation of human ERbeta expressed in HEK293 cells after 18 hrs by luciferase reporter gene assay, EC50=0.0000617μM | 20408532 | |
HEK293 | Function assay | 18 hrs | Transactivation of human ERalpha expressed in HEK293 cells after 18 hrs by luciferase reporter gene assay, EC50=0.0000646μM | 20408532 | |
HeLa | Function assay | 18 hrs | Displacement of [2,4,6,7-3H]estradiol from human ERalpha expressed in HeLa cells after 18 hrs by liquid scintillation counting, Ki=0.00016μM | 20621492 | |
U2OS | Function assay | 18 hrs | Agonist activity at ERbeta-LBD in human U2OS cells transfected with Gal4-DBD assessed as increase of transactivation activity after 18 hrs by luciferase reporter gene assay, EC50=0.0004581μM | 20812681 | |
U2OS | Function assay | 18 hrs | Agonist activity at ERalpha-LBD in human U2OS cells transfected with Gal4-DBD assessed as increase of transactivation activity after 18 hrs by luciferase reporter gene assay, EC50=0.002773μM | 20812681 | |
U2OS | Function assay | 18 hrs | Antagonist activity at ERbeta-LBD in human U2OS cells transfected with Gal4-DBD assessed as inhibition of transactivation activity after 18 hrs by luciferase reporter gene assay, IC50=0.01074μM | 20812681 | |
U2OS | Function assay | 18 hrs | Antagonist activity at ERalpha-LBD in human U2OS cells transfected with Gal4-DBD assessed as inhibition of transactivation activity after 18 hrs by luciferase reporter gene assay, IC50=0.02104μM | 20812681 | |
MCF7 | Function assay | up to 6 days | Agonist activity at human ERalpha LBD in human MCF7 cells assessed as induction of cell proliferation after up to 6 days by celltiter-glo assay, EC50=0.01μM | 21218783 | |
HEC1 | Function assay | 24 hrs | Agonist activity at human full-length ERalpha receptor expressed in human HEC1 cells co-expressing (ERE)2-pS2-luc gene assessed as transcriptional activation after 24 hrs by luciferase reporter gene assay, EC50=0.00009μM | 21481497 | |
HEC1 | Function assay | 24 hrs | Agonist activity at human full-length ERbeta receptor expressed in human HEC1 cells co-expressing (ERE)2-pS2-luc gene assessed as transcriptional activation after 24 hrs by luciferase reporter gene assay, EC50=0.00072μM | 21481497 | |
HEK | Function assay | 18 hrs | Agonist activity at ERalpha expressed in HEK cells co-expressing beta-lactamase after 18 hrs by beta-lactamase reporter gene assay, EC50=0.000046μM | 21885279 | |
UAS | Function assay | 18 hrs | Agonist activity at ERbeta expressed in UAS cells co-expressing beta-lactamase after 18 hrs by beta-lactamase reporter gene assay, EC50=0.00025μM | 21885279 | |
HEC-1 | Function assay | 24 hrs | Agonist activity at human ERalpha expressed in HEC-1 cells coexpressing beta-gal assessed as luciferase activity after 24 hrs by reporter gene assay, EC50=0.000123μM | 22122563 | |
U2OS | Function assay | 24 hrs | Agonist activity at human ERalpha expressed in U2OS cells coexpressing pCMX-hSRC3 assessed as luciferase activity after 24 hrs by reporter gene assay, EC50=0.00015μM | 22122563 | |
HEC-1 | Function assay | 24 hrs | Agonist activity at human ERbeta expressed in HEC-1 cells coexpressing beta-gal assessed as luciferase activity after 24 hrs by reporter gene assay, EC50=0.0002μM | 22122563 | |
U2OS | Function assay | 24 hrs | Agonist activity at human ERbeta expressed in U2OS cells coexpressing pCMX-hSRC3 assessed as luciferase activity after 24 hrs by reporter gene assay, EC50=0.0004μM | 22122563 | |
BL21 | Function assay | 1 hr | Agonist activity at human N-His6-tagged terbium-labelled NRID-SRC3 of ERalpha ligand binding domain expressed in Escherichia coli BL21 cells after 1 hr by TR-FRET assay, EC50=0.00056μM | 22122563 | |
BL21 | Function assay | 1 hr | Agonist activity at human N-His6-tagged terbium-labelled NRID-SRC3 of ERbeta ligand binding domain expressed in Escherichia coli BL21 cells after 1 hr by TR-FRET assay, EC50=0.0009μM | 22122563 | |
BL21 | Function assay | 1 hr | Agonist activity at human N-His6-tagged terbium-labelled ERbeta ligand binding domain expressed in Escherichia coli BL21 cells assessed as recruitment of fluorescein-labelled SRC3 after 1 hr by TR-FRET assay, EC50=0.0015μM | 22122563 | |
BL21 | Function assay | 1 hr | Agonist activity at human N-His6-tagged terbium-labelled ERalpha ligand binding domain expressed in Escherichia coli BL21 cells assessed as recruitment of fluorescein-labelled SRC3 after 1 hr by TR-FRET assay, EC50=0.003μM | 22122563 | |
Ishikawa cells | Function assay | 3 days | Agonist activity at estrogen receptor in human Ishikawa cells assessed as increase of alkaline phosphatase level after 3 days using P-nitrophenyl phosphate as substrate, EC50=0.0009μM | 22178552 | |
HepG2 | Function assay | 24 hrs | Agonist activity at human ERalpha expressed in HepG2 cells after 24 hrs by luciferase reporter gene assay, EC50=0.0022μM | 22283328 | |
HepG2 | Function assay | 24 hrs | Agonist activity at human ERbeta expressed in HepG2 cells after 24 hrs by luciferase reporter gene assay, EC50=0.011μM | 22283328 | |
MCF7 | Antiproliferative assay | 72 hrs | Antiproliferative activity against estrogen-deficient human MCF7 cells after 72 hrs by MTT assay, EC50=0.0000064μM | 22464681 | |
MCF7:D5L | Function assay | 16 hrs | Estrogenic activity at estrogen receptor in human MCF7:D5L cells co-expressing ERE assessed as induction of luciferase gene expression after 16 hrs by microplate reader, EC50=0.0000196μM | 22464681 | |
Ishikawa cells | Function assay | 72 hrs | Estrogenic activity at estrogen receptor in human Ishikawa cells assessed as induction of alkaline phosphatase expression after 72 hrs by microplate reader, EC50=0.0000246μM | 22464681 | |
CHO-K1 | Function assay | 24 hrs | Transcriptional activation of ERbeta receptor expressed in CHO-K1 cells after 24 hrs by luciferase reporter gene assay, EC50=0.000036μM | 22647217 | |
CHO-K1 | Function assay | 24 hrs | Transcriptional activation of ERalpha receptor expressed in CHO-K1 cells after 24 hrs by luciferase reporter gene assay, EC50=0.00005μM | 22647217 | |
yeast AH109 | Function assay | 24 hrs | Agonist activity at ERalpha receptor LBD expressed in yeast AH109 cells assessed as compound concentration at which 10% agonist activity of the maximum activity of E2 after 24 hrs by alpha-galactosidase assay, Activity=0.0001μM | 22647217 | |
yeast AH109 | Function assay | 24 hrs | Agonist activity at ERbeta receptor LBD expressed in yeast AH109 cells assessed as compound concentration at which 10% agonist activity of the maximum activity of E2 after 24 hrs by alpha-galactosidase assay, Activity=0.00018μM | 22647217 | |
yeast AH109 | Function assay | 24 hrs | Agonist activity at ERalpha receptor LBD expressed in yeast AH109 cells assessed as interaction with SRC1 after 24 hrs by alpha-galactosidase assay, EC50=0.00105μM | 22647217 | |
yeast AH109 | Function assay | 24 hrs | Agonist activity at ERbeta receptor LBD expressed in yeast AH109 cells assessed as interaction with SRC1 after 24 hrs by alpha-galactosidase assay, EC50=0.00108μM | 22647217 | |
MCF7:WS8 | Function assay | 48 hrs | Agonist activity at ER in human MCF7:WS8 cells assessed as increase in pS2 gene expression at 10'-10 M after 48 hrs by RT-PCR analysis | 24805199 | |
MCF7:WS8 | Function assay | 48 hrs | Agonist activity at ER in human MCF7:WS8 cells assessed as increase in GREB1 gene expression at 10'-10 M after 48 hrs by RT-PCR analysis | 24805199 | |
MCF7:WS8 | Function assay | 48 hrs | Agonist activity at ER in human MCF7:WS8 cells assessed as increase in PgR gene expression at 10'-10 M after 48 hrs by RT-PCR analysis | 24805199 | |
MCF7 | Antiproliferative assay | 2 days | Antiproliferative activity human ER-positive MCF7 cells after 2 days by MTT assay, IC50=27.35μM | 25222876 | |
MDA-MB-231 | Antiproliferative assay | 2 days | Antiproliferative activity human ER-negative MDA-MB-231 cells after 2 days by MTT assay, IC50=33.46μM | 25222876 | |
B16F10 | Antiproliferative assay | 2 days | Antiproliferative activity mouse B16F10 cells after 2 days by MTT assay, IC50=39.81μM | 25222876 | |
MIAPaCa2 | Antiproliferative assay | 2 days | Antiproliferative activity human MIAPaCa2 cells after 2 days by MTT assay, IC50=42.93μM | 25222876 | |
MCF7 | Function assay | 24 hrs | Agonist activity at human ERalpha in human MCF7 cells assessed as progesterone receptor endogenous genes activation after 24 hrs by qPCR, EC50=0.0000084μM | 25559213 | |
HEC1 | Function assay | 24 hrs | Agonist activity at human ERalpha expressed in human HEC1 cells assessed as transcriptional activation after 24 hrs by ERE-luciferase reporter gene transfection assay, EC50=0.00016μM | 25559213 | |
MCF7 | Function assay | 24 hrs | Agonist activity at human ERbeta in human MCF7 cells assessed as otubain 2 endogenous genes activation after 24 hrs by qPCR, EC50=0.0003μM | 25559213 | |
HEC1 | Function assay | 24 hrs | Agonist activity at human ERbeta expressed in human HEC1 cells assessed as transcriptional activation after 24 hrs by ERE-luciferase reporter gene transfection assay, EC50=0.00038μM | 25559213 | |
insect cells | Function assay | 2 hrs | Displacement of fluormone-labeled ES2 from recombinant full length human ERalpha ligand binding domain expressed in insect cells after 2 hrs by TR-FRET assay, IC50=0.00041μM | 28105283 | |
Ishikawa cells | Function assay | 96 hrs | Estrogenic activity at estrogen receptor alpha in human Ishikawa cells assessed as induction of alkaline phosphatase activity using p-Nitrophenol phosphate as substrate pretreated for 96 hrs followed by substrate addition measured every 15 secs by scannin, EC50=0.0002μM | 28812892 | |
Ishikawa | Function assay | 96 hrs | Estrogenic activity at ERalpha in human Ishikawa cells assessed as induction of alkaline phosphatase activity using p-nitrophenol as substrate treated for 96 hrs followed by substrate addition by spectrophotometric method, EC50=0.00003μM | 29641206 | |
MDA-MB-231/beta41 | Function assay | 18 hrs | Estrogenic activity at ERbeta (unknown origin) expressed in human MDA-MB-231/beta41 cells after 18 hrs by renilla luciferase reporter gene assay, EC50=0.00003μM | 29641206 | |
insect cells | Function assay | 2 hrs | Inhibition of fluoromone binding to recombinant human full length untagged ERbeta expressed in insect cells after 2 hrs by fluorescence polarization assay, IC50=0.00128μM | 29869503 | |
insect cells | Function assay | 2 hrs | Inhibition of fluoromone binding to recombinant human full length untagged ERalpha expressed in insect cells after 2 hrs by fluorescence polarization assay, IC50=0.004804μM | 29869503 | |
HEK293T | Function assay | 24 hrs | Agonist activity at ER-beta (unknown origin) transfected in HEK293T cells after 24 hrs by Steady-Glo luciferase reporter gene assay, EC50=0.0000398μM | ChEMBL | |
HEK293T | Function assay | 24 hrs | Agonist activity at ER-alpha (unknown origin) transfected in HEK293T cells after 24 hrs by Steady-Glo luciferase reporter gene assay, EC50=0.0001μM | ChEMBL | |
HeLa | Function assay | Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor beta., EC50=0.00007μM | 11906280 | ||
HeLa | Function assay | Activation of estrogen response element in HeLa cells stably transfected with human Estrogen receptor alpha., EC50=0.00002μM | 11906280 | ||
MCF-7 | Function assay | Agonist effect on transcriptional activation in MCF-7 cells expressing estrogen receptor alpha, EC50=0.000007μM | 10673099 | ||
HRPE | Function assay | TP_TRANSPORTER: inhibition of TEA uptake (TEA: 20 uM) in OCT3-expressing HRPE cells, IC50=1.1μM | 9830022 | ||
MCF-7 | Function assay | Affinity for estrogen receptor of human MCF-7 cells, EC50=0.00018μM | 9371241 | ||
MCF-7 | Function assay | Induction of pS2 Gene expression in human MCF-7 cells, EC50=0.0000301μM | 9371241 | ||
MCF-7 | Function assay | Growth response in cultures of MCF-7 (human breast cancer cell line) cells, EC50=0.0000015μM | 9357533 | ||
HeLa | Function assay | TP_TRANSPORTER: inhibition of E217betaG uptake in Oatp1-expressing HeLa cells, Ki=4.7μM | 8779894 | ||
mammary cancer cells | Function assay | Affinity estrogen receptor of MCF-7 human mammary cancer cells, EC50=0.0038μM | 8627615 | ||
MCF-7 | Function assay | Induction of pS2 mRNA expression in human MCF-7 mammary carcinoma cells, EC50=0.000292μM | 8627615 | ||
MCF-7 | Function assay | Induction of pS2 mRNA expression in human MCF-7 mammary carcinoma cells, EC50=0.0000996μM | 8627615 | ||
Ishikawa cells | Function assay | Concentration of compound required to induce 50 % of the maximum stimulation of alkaline phosphatase activity in Ishikawa cells, EC50=0.00001μM | 8201587 | ||
MCF-7 | Function assay | Effective dose for [3H]- estradiol against proliferation of MCF-7 cells, EC50=0.00002μM | 2769681 | ||
MCF-7 | Function assay | Displacement of [3H]estradiol from Estrogen receptor in MCF-7 cells, IC50=0.003μM | 1548683 | ||
SH-SY5Y | Function assay | Agonist activity in transcriptional activation assay in SH-SY5Y neuroblastoma cells expressing Estrogen receptor beta, EC50=0.0001μM | 11906280 | ||
HEK293 | Function assay | TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 0.25 uM) in OCT3-expressing HEK293 cells, IC50=2.88μM | 12110607 | ||
HEK293 | Function assay | TP_TRANSPORTER: inhibition of MPP+ uptake (MPP+: 0.25 uM) in OCT1-expressing HEK293 cells, IC50=5.73μM | 12110607 | ||
MCF-7-2a | Function assay | Agonist activity in transcriptional activation assay in MCF-7-2a cells compared to estradiol E2, EC50=0.00049μM | 12139447 | ||
T47D | Function assay | Agonist effect on transcriptional activation in T47D cells expressing estrogen receptor alpha, EC50=0.00007μM | 12459017 | ||
T47D | Function assay | Agonist effect on transcriptional activation of T47D cells expressing human estrogen receptor beta, EC50=0.0008μM | 12459017 | ||
MCF-7 | Function assay | Percent agonistic activity for estrogen-induced pS2 expression in MCF-7 cells, EC50=0.00001μM | 12749898 | ||
MCF-7 | Function assay | Functional ERalpha receptor activity in transcriptional activation assay in MCF-7 cells, ED50=0.0000046μM | 12824043 | ||
SAOS-2 | Function assay | Functional Estrogen receptor beta activity by metallothionein induction in SAOS-2 cells, ED50=0.0047μM | 12824043 | ||
MCF-7 breast tumor | Function assay | Effective concentration against MCF-7 breast tumor cells using MCF-7 assay., EC50=0.00001μM | 12825935 | ||
MCF-7-2a | Function assay | Concentration required to activate luciferase expression in MCF-7-2a cells, EC50=0.00008μM | 14761193 | ||
HeLa | Function assay | Inhibition of [3H]estradiol binding to human estrogen receptor beta expressed in HeLa cells, IC50=0.024μM | 15658851 | ||
HeLa | Function assay | Inhibition of [3H]estradiol binding to human estrogen receptor alpha expressed in HeLa cells, IC50=0.028μM | 15658851 | ||
COS-1 | Function assay | In vitro agonist activity for estrogen receptor alpha expressed in COS-1 cells, EC50=0.0024μM | 15713407 | ||
COS-1 | Function assay | In vitro agonist activity for estrogen receptor beta expressed in COS-1 cells, EC50=0.0097μM | 15713407 | ||
293T | Function assay | Displacement of [3H]17beta-estradiol from recombinant human ERalpha expressed in 293T cells, IC50=0.00075μM | 16219463 | ||
293T | Function assay | Displacement of [3H]17beta-estradiol from recombinant human ERbeta expressed in 293T cells, IC50=0.00118μM | 16219463 | ||
HEK293 | Function assay | Effect on transactivation of ALP gene expression in HEK293 cells transfected with hERalpha, EC50=0.00075μM | 16309907 | ||
HEK293 | Function assay | Effect on transactivation of ALP gene expression in HEK293 cells transfected with hERbeta, EC50=0.0021μM | 16309907 | ||
COS7 | Function assay | Displacement of E2-Alexa633 from GFP-tagged ERalpha expressed in COS7 cells by FACS, Ki=0.0003μM | 16520733 | ||
COS7 | Function assay | Agonist activity at GFP-tagged GPR30 expressed in COS7 cells assessed as half life for increase in intracellular calcium level by spectrofluorimetry, EC50=0.0003μM | 16520733 | ||
COS7 | Function assay | Displacement of E2-Alexa633 from GFP-tagged ERbeta expressed in COS7 cells by FACS, Ki=0.00038μM | 16520733 | ||
COS7 | Function assay | Displacement of E2-Alexa633 from GFP-tagged GPR30 expressed in COS7 cells by FACS, Ki=0.0057μM | 16520733 | ||
HEK293 | Function assay | Agonist activity at human recombinant ERalpha expressed in HEK293 cells by transactivation assay, EC50=0.00075μM | 17448656 | ||
HEK293 | Function assay | Agonist activity at human recombinant ERbeta expressed in HEK293 cells by transactivation assay, EC50=0.0021μM | 17448656 | ||
HEK293 | Function assay | Agonist activity at ERalpha expressed in HEK293 cells by transactivation assay, EC50=0.00075μM | 17890084 | ||
HEK293 | Function assay | Agonist activity at ERbeta expressed in HEK293 cells by transactivation assay, EC50=0.0021μM | 17890084 | ||
MCF7 BUS | Function assay | Estrogenic potency in human MCF7 BUS cells assessed as drug level inducing maximal cell proliferation, MED=0.001μM | 18242997 | ||
CHO | Function assay | Agonist activity at human TGR5 expressed in CHO cells by luciferase assay, EC50=38.4μM | 18307294 | ||
BL21(DE3) | Function assay | Agonist activity at human ERalpha ligand binding domain expressed in Escherichia coli BL21(DE3) cells assessed as induction of coactivator 53-protein binding by fluorescence assay | 19561619 | ||
BL21(DE3) | Function assay | Agonist activity at human ERbeta ligand binding domain expressed in Escherichia coli BL21(DE3) cells assessed as induction of coactivator 53-protein binding by fluorescence assay | 19561619 | ||
SF9 | Function assay | Displacement of [3H]17beta-estradiol from human ERalpha expressed in SF9 cells, IC50=0.0125μM | 19836949 | ||
COS7 | Function assay | Agonist activity at estrogen receptor alpha ligand binding domain expressed in african green monkey COS7 cells co-transfected with Gal4-LBD by luciferase reporter gene assay, EC50=0.0032μM | 19863083 | ||
COS7 | Function assay | Agonist activity at estrogen receptor beta ligand binding domain expressed in african green monkey COS7 cells co-transfected with Gal4-LBD by luciferase reporter gene assay, EC50=0.011μM | 19863083 | ||
MCF7:WS8 | Function assay | Activation of human ER in human MCF7:WS8 cells expressing estrogen responsive element by luciferase reporter gene assay | 20334368 | ||
T47D:C:4:2 | Function assay | Estrogenic activity at wild type ER alpha expressed in T47D:C:4:2 cells coexpressing estrogen response element by duel luciferase reporter gene assay | 20334368 | ||
T47D:C:4:2 | Function assay | Estrogenic activity at wild type ER alpha D351G mutant expressed in T47D:C:4:2 cells coexpressing estrogen response element by duel luciferase reporter gene assay | 20334368 | ||
CHO-K1 | Function assay | Agonist activity at ERbeta expressed in CHO-K1 cells by luciferase reporter gene transactivation assay, EC50=0.03μM | 20553023 | ||
CHO-K1 | Function assay | Agonist activity at ERalpha expressed in CHO-K1 cells by luciferase reporter gene transactivation assay, EC50=0.05μM | 20553023 | ||
HEK293T | Function assay | Agonist activity at human ERalpha E353A mutant expressed in HEK293T cells co-expressing ERE assessed as transactivation activity by luciferase reporter gene assay, EC50=0.0025μM | 20659801 | ||
HEK293T | Function assay | Agonist activity at human ERbeta E305A mutant expressed in HEK293T cells co-expressing ERE assessed as transactivation activity by luciferase reporter gene assay, EC50=0.0104μM | 20659801 | ||
HeLa | Function assay | Agonist activity at human wild type ERalpha expressed in human HeLa cells co-expressing ERE assessed as transactivation activity by luciferase reporter gene assay | 20659801 | ||
HeLa | Function assay | Transactivation of human wild type ERalpha expressed in human HeLa cells co-expressing AP-1 by luciferase reporter gene assay | 20659801 | ||
HeLa | Function assay | Agonist activity at human wild type ERbeta expressed in human HeLa cells co-expressing ERE assessed as transactivation activity by luciferase reporter gene assay | 20659801 | ||
HeLa | Function assay | Antagonist activity at human wild type ERbeta expressed in human HeLa cells co-expressing AP-1 assessed as inhibition of transactivation activity by luciferase reporter gene assay | 20659801 | ||
HEK293 | Function assay | Agonist activity at ZFP-fused ERRbeta LBD expressed in HEK293 cells by TR-FRET assay, EC50=0.0046μM | 21218783 | ||
U2-OS | Function assay | Activation of human ERalpha expressed in human U2-OS cells by luciferase reporter gene assay relative to untreated control, EC50=0.000004μM | 23043242 | ||
U2-OS | Function assay | Activation of human ERbeta expressed in human U2-OS cells by luciferase reporter gene assay relative to untreated control, EC50=0.00001μM | 23043242 | ||
MCF7/2a | Function assay | Activation of ERalpha in human MCF7/2a cells by luciferase reporter gene assay relative to untreated control, EC50=0.0001μM | 23043242 | ||
HEK293 | Function assay | Agonist activity at human ERalpha expressed in HEK293 cells by luciferase reporter gene assay, EC50=0.000024μM | 25305688 | ||
HEK293 | Function assay | Agonist activity at human ERbeta expressed in HEK293 cells by luciferase reporter gene assay, EC50=0.000085μM | 25305688 | ||
insect cells | Function assay | Displacement of Fluormone ES2 Green from human recombinant full length ERalpha expressed in insect cells measured up to 4 hrs by fluorescence polarization assay, IC50=0.0044μM | 27647375 | ||
insect cells | Function assay | Inhibition of fluormone ES2 binding to recombinant full length human ERbeta expressed in insect cells by fluorescence polarization assay, IC50=0.00665μM | 28735214 | ||
293 cells | Function assay | Binding affinity to ER (unknown origin) expressed in UAS-bla GripTite 293 cells by Select screen competitive binding assay, EC50=0.0023μM | 28886996 | ||
HEk293 | Function assay | Agonist activity at recombinant human GAL4-fused ERalpha expressed in HEk293 cells by luciferase reporter gene assay, EC50=0.00011μM | 29525335 | ||
293 cells | Function assay | Agonist activity at GAL4 DNA-binding domain fused ERalpha (unknown origin) ligand binding domain expressed in UAS-bla GripTite 293 cells assessed as beta-lactamase transcriptional activation by FRET-based GeneBLAzer assay, IC50=0.000107μM | 30144697 | ||
293 cells | Function assay | Agonist activity at GAL4 DNA-binding domain fused ERbeta (unknown origin) ligand binding domain expressed in UAS-bla GripTite 293 cells assessed as beta-lactamase transcriptional activation by FRET-based GeneBLAzer assay, IC50=0.000579μM | 30144697 | ||
HEK293 | Function assay | Selective estrogen receptor down-regulator activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ERalpha degradation by luciferase reporter gene assay, EC50=0.00009μM | 30940565 | ||
HEK293 | Function assay | Agonist activity at FLAG-tagged ERalpha (unknown origin) expressed in HEK293 cells assessed as induction of ER-alpha-mediated transcriptional activity by luciferase reporter gene assay, EC50=0.00013μM | 30940565 | ||
Sf9 | Function assay | Binding Assay: The method employed was adapted from the scientific literature and described in detail by Osbourn et al. (1993, Biochemistry, 32, 6229-6236). Recombinant human ERalpha and ERR proteins were purified from transfected Sf9-cells. The in vitro , Ki=0.000015μM | ChEMBL | ||
Sf9 | Function assay | Inhibition Assay: The method employed was adapted from the scientific literature and described in detail by Osboum et al. (1993, Biochemistry, 32, 6229-6236). Recombinant human ERalpha and ERbeta proteins were purified from transfected Sf9-cells. The in v, Ki=0.000015μM | ChEMBL | ||
Sf9 | Function assay | Binding Assay: The method employed was adapted from the scientific literature and described in detail by Osbourn et al. (1993, Biochemistry, 32, 6229-6236). Recombinant human ERalpha and ERR proteins were purified from transfected Sf9-cells. The in vitro , Ki=0.00021μM | ChEMBL | ||
Sf9 | Function assay | Inhibition Assay: The method employed was adapted from the scientific literature and described in detail by Osboum et al. (1993, Biochemistry, 32, 6229-6236). Recombinant human ERalpha and ERbeta proteins were purified from transfected Sf9-cells. The in v, Ki=0.00021μM | ChEMBL | ||
CV-1 | Luciferase Assay | Luciferase Assay: Estrogen receptor-negative CV-1 kidney cells are maintained in Dulbecco's modified Eagle's medium with 4.5 g/L glucose supplemented with 10% fetal bovine serum and 100 units/ml penicillin-streptomycin at 37° C. in a humidified 5% CO2 atm, IC50=0.0017μM | ChEMBL | ||
CV-1 | Luciferase Assay | Luciferase Assay: Estrogen receptor-negative CV-1 kidney cells are maintained in Dulbecco's modified Eagle's medium with 4.5 g/L glucose supplemented with 10% fetal bovine serum and 100 units/ml penicillin-streptomycin at 37° C. in a humidified 5% CO2 atm, IC50=0.0019μM | ChEMBL | ||
COS7 | Function assay | Competitive binding affinity to G-protein coupled estrogen receptor (unknown origin) expressed in COS7 cells by E2 Alexa 633 staining based fluorescence analysis, Ki=0.0027μM | ChEMBL | ||
點擊查看更多細胞系數(shù)據(jù) |
產(chǎn)品描述 | Estradiol (17β-estradiol, β-Estradiol, E2, 17β-Oestradiol)是一種人類性激素和類固醇,也是主要的女性性激素。Estradiol 可通過 estrogen receptor β (ERβ) 通路來上調 IL-6 的表達。 | |
---|---|---|
靶點 |
|
體外研究(In Vitro) | ||||
體外研究活性 | Estradiol誘導海馬CA1錐體細胞產(chǎn)生新的樹突棘和突觸。Estradiol治療導致NMDA受體增加46%結合力。Estradiol治療增加NMDA受體結合以及相應的樹突棘和突觸密度。Estradiol處理導致CA1區(qū)錐體細胞對NMDA受體介導的突觸輸入的敏感性增加,而這種增加與這些細胞的頂樹突樹中Estradiol誘導樹突棘密度的增加有很好的相關性。[1] 在急性分離和培養(yǎng)的紋狀體神經(jīng)元中,17 beta-estradiol可逆地通過鋇離子通道減少鈣離子進入。 17 alpha-estradiol也減少了鋇離子電流,但是顯著比17 beta-estradiol對大鼠紋狀體神經(jīng)元的效果較差。[2] 17 beta-estradiol劑量依賴性抑制IL-1,TNF-α和IL-1和TNF-α誘導的IL-6的產(chǎn)生。Estradiol抑制新生小鼠顱蓋骨來源的原骨細胞培養(yǎng)物中TNF-α誘導的IL-6的產(chǎn)生和破骨細胞的生成。[3] |
|||
---|---|---|---|---|
實驗圖片 | 檢測方法 | 檢測指標 | 實驗圖片 | PMID |
Western blot | p-GSK3β / GSK3 β-catenin Survivin / ER-alpha / NgBR ERα / FOXP1 / KRAS / PTEN | 19360103 |
體內研究(In Vivo) | ||
體內研究活性 | Estradiol調節(jié)成年大鼠發(fā)情周期內海馬突觸密度的波動。[4] Estradiol可以獨自扭轉卵巢切除引發(fā)的脊椎密度的減少。Estradiol結合Progesterone先增加脊椎密度,為期2至6小時,但隨后產(chǎn)生比單獨Estradiol處理更大的降低。[5] |
---|
NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
---|---|---|---|---|---|
NCT05900895 | Not yet recruiting | Metastatic Breast Cancer |
Mary D Chamberlin|Dartmouth-Hitchcock Medical Center |
May 2024 | Phase 1 |
NCT06380205 | Recruiting | Healthy Participants |
Incyte Corporation |
May 7 2024 | Phase 1 |
NCT06334315 | Not yet recruiting | Contraception|Pharmacogenomic Drug Interaction |
Yale University|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) |
May 2024 | Phase 4 |
分子量 | 272.38 | 分子式 | C18H24O2 |
CAS號 | 50-28-2 | SDF | Download Estradiol SDF |
Smiles | CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O | ||
儲存條件(自收到貨起) | |||
體外溶解度 |
DMSO : 54 mg/mL ( (198.25 mM) ;DMSO吸濕會降低化合物溶解度,請使用新開封DMSO) Ethanol : 54 mg/mL (198.25 mM) Water : Insoluble |
摩爾濃度計算器 |
體內溶解度 現(xiàn)配現(xiàn)用,請按從左到右的順序依次添加,澄清后再加入下一溶劑 |
動物體內配方計算器 |
動物體內配方計算器(澄清溶液)
第一步:請輸入基本實驗信息(考慮到實驗過程中的損耗,建議多配一只動物的藥量)
第二步:請輸入動物體內配方組成(配方適用于不溶于水的藥物;不同批次藥物配方比例不同,請聯(lián)系Selleck為您提供正確的澄清溶液配方)
計算結果:
工作液濃度: mg/ml;
DMSO母液配制方法: mg 藥物溶于μL DMSO溶液(母液濃度mg/mL,注:如該濃度超過該批次藥物DMSO溶解度,請先聯(lián)系Selleck);
體內配方配制方法:取μL DMSO母液,加入μL PEG300,混勻澄清后加入μL Tween 80,混勻澄清后加入μL ddH2O,混勻澄清。
體內配方配制方法:取μL DMSO母液,加入μL Corn oil,混勻澄清。
注意:1. 首先保證母液是澄清的;
2.一定要按照順序依次將溶劑加入,進行下一步操作之前必須保證上一步操作得到的是澄清的溶液,可采用渦旋、超聲或水浴加熱等物理方法助溶。
在訂購、運輸、儲存和使用我們的產(chǎn)品的任何階段,您遇到的任何問題,均可以通過撥打我們的熱線電話400-668-6834,或者技術支持郵箱tech@selleck.cn,直接聯(lián)系到我們。我們會在24小時內盡快聯(lián)系您。
如果有其他問題,請給我們留言。
* 必填項